Berlin, Berlin, Germany The fund was located in Europe if to be more exact in Germany. The main department of described VC is located in the Berlin.
This Chione works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2015. The fund is constantly included in less than 2 deals per year. Speaking about the real fund results, this VC is 80 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2013.
Among the most popular portfolio startups of the fund, we may highlight Sera Prognostics, Karyopharm Therapeutics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Biotechnology, Hospital. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Chione, startups are often financed by Upstart Life Ventures, Techstars Berlin Accelerator, Techstars. The meaningful sponsors for the fund in investment in the same round are Upstart Life Ventures, Domain Associates, Catalyst Health Ventures. In the next rounds fund is usually obtained by Delphi Ventures, Catalyst Health Ventures, Upstart Life Ventures.
Related Funds
| Fund Name | Location |
| 350 Investment Partners | England, United Kingdom, Warrington |
| AJI Capital | Huntington, New York, United States |
| Amarena | - |
| Australian Nuclear Science and Technology Organization | - |
| Contriber Ventures | Estonia, Tartu, Tartumaa |
| DRW Venture Partners | Austin, Texas, United States |
| Ehong Capital Co., Ltd. | - |
| Fenqile | China, Guangdong, Shenzhen |
| Grofers International | Central, Central Region, Singapore |
| Guangkong Kangfu Yongpin | China, Hong Kong, Hong Kong Island |
| Huaan Securities | Anhui, China, Hefei |
| J-POWER | Japan, Tokyo |
| M-Industry | Connecticut, Stamford, United States |
| Orbis Investment Management | Bermuda, Hamilton |
| Real Networks | Seattle, United States, Washington |
| Synergia Capital Partners | Netherlands, Utrecht, Veenendaal |
| webMethods | Fairfax, United States, Virginia |
| Yingke Capital | China, Fuzhou, Jiangxi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Prisma Photonics | $20M | 12 Sep 2023 | - | ||
Acrivon Therapeutics | $100M | 11 Nov 2021 | Cambridge, Massachusetts, United States | ||
Prisma Photonics | $10M | 01 Jan 2020 | - | ||
| 20 May 2016 | Berlin, Berlin, Germany | ||||
Sera Prognostics | $20M | 07 Jan 2015 | Salt Lake City, Utah, United States | ||
Sera Prognostics | $5M | 18 Nov 2014 | Salt Lake City, Utah, United States | ||
Karyopharm Therapeutics | $10M | 02 Nov 2011 | Newton, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Prisma Photonics | $20M | 12 Sep 2023 | - | ||
Acrivon Therapeutics | $100M | 11 Nov 2021 | Cambridge, Massachusetts, United States | ||
Prisma Photonics | $10M | 01 Jan 2020 | - | ||
| 20 May 2016 | Berlin, Berlin, Germany | ||||
Sera Prognostics | $20M | 07 Jan 2015 | Salt Lake City, Utah, United States | ||
Sera Prognostics | $5M | 18 Nov 2014 | Salt Lake City, Utah, United States | ||
Karyopharm Therapeutics | $10M | 02 Nov 2011 | Newton, Massachusetts, United States |
